Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,652 INR | +1.00% | +1.41% | -1.76% |
Feb. 09 | India's Zydus Lifesciences beats Q3 profit estimates; approves shares buyback | RE |
Feb. 08 | Transcript : Zydus Wellness Limited, Q3 2024 Earnings Call, Feb 08, 2024 |
Sales 2024 * | 23.19B 278M | Sales 2025 * | 26.27B 315M | Capitalization | 105B 1.26B |
---|---|---|---|---|---|
Net income 2024 * | 2.9B 34.88M | Net income 2025 * | 3.95B 47.41M | EV / Sales 2024 * | 4.5 x |
Net cash position 2024 * | 566M 6.8M | Net cash position 2025 * | 2.8B 33.58M | EV / Sales 2025 * | 3.89 x |
P/E ratio 2024 * |
34.9
x | P/E ratio 2025 * |
26.3
x | Employees | 975 |
Yield 2024 * |
0.45% | Yield 2025 * |
0.63% | Free-Float | 20.12% |
Latest transcript on Zydus Wellness Limited
1 day | +1.00% | ||
1 week | +1.41% | ||
Current month | +11.92% | ||
1 month | +10.78% | ||
3 months | +3.03% | ||
6 months | +9.76% | ||
Current year | -1.76% |
Managers | Title | Age | Since |
---|---|---|---|
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Umesh V. Parikh
DFI | Director of Finance/CFO | - | 18-02-06 |
Compliance Officer | - | 22-07-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 09-04-26 | |
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Director/Board Member | 50 | 19-03-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1,652 | +1.00% | 13 035 |
24-04-23 | 1,635 | -1.51% | 22,097 |
24-04-22 | 1,660 | +1.74% | 35,777 |
24-04-19 | 1,632 | +0.20% | 21,311 |
24-04-18 | 1,628 | +0.03% | 33,556 |
Delayed Quote NSE India S.E., April 24, 2024 at 07:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.98% | 95.17B | |
+2.03% | 46.28B | |
+1.50% | 40.93B | |
+8.29% | 39.98B | |
-0.43% | 38.2B | |
-16.16% | 31B | |
-5.89% | 28.94B | |
+14.07% | 25.4B | |
-10.01% | 22.48B |
- Stock Market
- Equities
- ZYDUSWELL Stock
- ZYDUSWELL Stock